High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.
Toulmonde M, Lucchesi C, Verbeke S, Crombe A, Adam J, Geneste D, Chaire V, Laroche-Clary A, Perret R, Bertucci F, Bertolo F, Bianchini L, Dadone-Montaudie B, Hembrough T, Sweet S, Kim YJ, Cecchi F, Le Loarer F, Italiano A.
Toulmonde M, et al. Among authors: bertolo f.
EBioMedicine. 2020 Dec;62:103131. doi: 10.1016/j.ebiom.2020.103131. Epub 2020 Nov 28.
EBioMedicine. 2020.
PMID: 33254023
Free PMC article.